- Home
- AUID vs ADAG Comparison
AUID vs ADAG Comparison
Compare AUID & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUID
- ADAG
- Stock Information
- Founded
- AUID 2009
- ADAG 2011
- Country
- AUID United States
- ADAG China
- Employees
- AUID N/A
- ADAG N/A
- Industry
- AUID Computer Software: Prepackaged Software
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- AUID Technology
- ADAG Health Care
- Exchange
- AUID Nasdaq
- ADAG Nasdaq
- Market Cap
- AUID 74.7M
- ADAG 81.9M
- IPO Year
- AUID N/A
- ADAG 2021
- Fundamental
- Price
- AUID $5.51
- ADAG $2.06
- Analyst Decision
- AUID
- ADAG Strong Buy
- Analyst Count
- AUID 0
- ADAG 1
- Target Price
- AUID N/A
- ADAG $8.00
- AVG Volume (30 Days)
- AUID 22.8K
- ADAG 156.3K
- Earning Date
- AUID 03-19-2025
- ADAG 03-09-2025
- Dividend Yield
- AUID N/A
- ADAG N/A
- EPS Growth
- AUID N/A
- ADAG N/A
- EPS
- AUID N/A
- ADAG N/A
- Revenue
- AUID $758,638.00
- ADAG $815,746.00
- Revenue This Year
- AUID N/A
- ADAG N/A
- Revenue Next Year
- AUID N/A
- ADAG $2.70
- P/E Ratio
- AUID N/A
- ADAG N/A
- Revenue Growth
- AUID 97.40
- ADAG N/A
- 52 Week Low
- AUID $4.62
- ADAG $1.64
- 52 Week High
- AUID $12.31
- ADAG $3.65
- Technical
- Relative Strength Index (RSI)
- AUID 35.80
- ADAG 62.66
- Support Level
- AUID $6.49
- ADAG $1.64
- Resistance Level
- AUID $7.49
- ADAG $1.95
- Average True Range (ATR)
- AUID 0.63
- ADAG 0.10
- MACD
- AUID -0.14
- ADAG 0.04
- Stochastic Oscillator
- AUID 0.50
- ADAG 91.30
About AUID authID Inc.
AuthID Inc is a company engaged in ensuring cyber-savvy enterprises "Know Who's Behind the Device" for every customer or employee login and transaction. Through its easy-to-integrate, patented, biometric identity platform, authID quickly and accurately verifies a user's identity, eliminating any assumption of who is behind a device and preventing cybercriminals from taking over accounts. authID combines digital onboarding, biometric passwordless authentication and account recovery, with a fast, accurate, user-friendly experience-delivering identity verification.
About ADAG Adagene Inc.
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.